TRANSGENE (EPA:TNG) | Finanzwire

Basculer en Français

10793	Companies
233179	Keywords
161777	Articles
124386	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 09/14/2024 at 09:05, 1 year 10 months ago

Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments
Transgene and BioInvent present promising early results of oncolytic virus BT-001 in ESMO 2024, showing antitumor activity in solid tumors. BT-001 induces tumor regression and enhances T cell infiltration

Transgene Oncolytic Virus BioInvent Antitumor Activity ESMO 2024
BRIEF

published on 09/13/2024 at 10:37, 1 year 10 months ago

Threshold crossing by SITAM Belgium in TRANSGENE SA

Voting Rights Capital Increase Threshold Crossing SITAM Belgium TRANSGENE SA
BRIEF

published on 09/10/2024 at 07:35, 1 year 10 months ago

Transgene Appoints Two Seasoned Leaders in Oncology to Drive its Next Phase of Innovation

Cancer Treatment Oncology Leadership Immunotherapy Transgene
PRESS RELEASE

published on 09/10/2024 at 07:30, 1 year 10 months ago

Transgene Appoints Two Seasoned Leaders in Oncology to Drive its Next Phase of Innovation
Transgene appoints Dr. Emmanuelle Dochy as CMO and Dr. Maurizio Ceppi as CSO to drive innovation in cancer immunotherapies. Company progresses clinical pipeline with therapeutic vaccine TG4050

Innovation Oncology Clinical Pipeline Immunotherapy Transgene
BRIEF

published on 08/27/2024 at 07:35, 1 year 11 months ago

Transgene Publishes Preclinical Data on Oncolytic Virus TG6050 in JITC

Preclinical Data Transgene Oncolytic Virus TG6050 JITC
PRESS RELEASE

published on 08/27/2024 at 07:30, 1 year 11 months ago

Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 published in JITC
Transgene announces preclinical proof-of-concept data of oncolytic virus TG6050 published in JITC, showcasing tumor regression and immune remodeling capabilities without systemic toxicity. TG6050 progressing in Phase I trial for NSCLC

Phase I Trial Transgene Oncolytic Virus TG6050 JITC Publication
BRIEF

published on 07/30/2024 at 21:06, 2 years ago

Transgene consolidates its balance sheet thanks to the conversion of part of the advance into shares

Biotechnology Immunotherapy Increase In Capital Transgene Mérieux Institute
BRIEF

published on 06/03/2024 at 07:35, 2 years 1 month ago

Transgene includes the first patient in Phase II of the study of its TG4050 vaccine against head and neck cancers

Head And Neck Cancer Transgene TG4050 Phase II Therapeutic Vaccine
PRESS RELEASE

published on 06/03/2024 at 07:30, 2 years 1 month ago

Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer
Transgene enrolls first patient in Phase II of randomized Phase I/II trial for cancer vaccine TG4050 in head and neck cancer, with completion expected in Q4 2025

Phase II Trial Head And Neck Cancer Cancer Vaccine Transgene TG4050
BRIEF

published on 05/14/2024 at 17:50, 2 years 2 months ago

Transgene Announces Positive Q1 2024 Update and Future Clinical Milestones

Clinical Trials Financial Update Cancer Immunotherapy Transgene TG4050

Accesswire

Published on 08/01/2026 at 01:20, 1 day 22 hours ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 22 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 22 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 1 day 23 hours ago

BioNxt Solutions Announces Option Grants
Published on 07/31/2026 at 23:20, 2 days ago

Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.

View all ACCESSWIRE

EQS Group

Published on 08/02/2026 at 08:15, 15 hours 10 minutes ago

Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 1 day 6 hours ago

HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 2 days 3 hours ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 2 days 4 hours ago

Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 18:55, 2 days 4 hours ago

Holding(s) in Company

Les Echos

Published on 07/31/2026 at 21:00, 2 days 2 hours ago

Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 2 days 3 hours ago

Share retention commitments (Dutreil Agreement)
Published on 07/31/2026 at 19:14, 2 days 4 hours ago

2026 First-Half financial report
Published on 07/31/2026 at 19:13, 2 days 4 hours ago

Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 2 days 4 hours ago

Covivio Hotels - 2026 Half-year financial report

View all LES ECHOS COMFI WIRE